Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease

BACKGROUND: The two biomarkers 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers are both recommended to support the diagnosis of Alzheimer’s disease. However, there is a lack of knowledge for the comparison of the two biomarkers in a routine clinical setting. OBJECTIVE: The aim was to compare the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Gjerum, Le, Andersen, Birgitte Bo, Bruun, Marie, Simonsen, Anja Hviid, Henriksen, Otto Mølby, Law, Ian, Hasselbalch, Steen Gregers, Frederiksen, Kristian Steen
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954298/
https://ncbi.nlm.nih.gov/pubmed/33711065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0248413
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы